posted June 24, 2022 09:17 am by RockLobster1
(40)
Patients recruitment initiated for U.S. Phase I/II rotator cuff tear repair clinical trial in June 2023 Philippe Deschamps appointed as new CEO Signing of Material Transfer
...read more
posted June 13, 2022 10:06 am by RockLobster1
(40)
ORTHO REGENERATIVE TECHNOLOGIES INITIATES PATIENTS RECRUITMENT FOR ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL
...read more
posted May 04, 2022 03:32 pm by Betteryear2
(3281)
New patent issued by U.S. Patent and Trademark Office to protect core IP until 2035 Positions Company as leading player in the dynamic regenerative medicine market Enables
...read more
posted February 07, 2022 07:34 am by RockLobster1
(40)
finally some real progress.... should be finally some results to show coming.
rate and reply
posted February 07, 2022 07:34 am by RockLobster1
(40)
MONTREAL, Feb. 7, 2022 /CNW/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTC: ORTIF) ("Ortho" or the "Company"), a clinical-stage orthobiologics company focused on the
...read more
posted December 13, 2021 11:39 am by Betteryear2
(3281)
MONTREAL, Dec. 13, 2021 /PRNewswire/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTCQB: ORTIF) ("Ortho" or the "Company"), a clinical-stage
...read more